Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

AZTA

Azenta Inc

Nov 20 • 01:17PM ET

30.03

0.00 0.00 %

Healthcare • Medical Instruments & Supplies • USA • NASD

Peers: DHR ILMN TMO A BIO HOLX WAT CTLT QGEN MMS

| Held by: IJR VTI IWM VB VBR ROBO VXF SPSM IWN DFSV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.43	Insider Own	2.04%	Shs Outstand	45.78M	Perf Week	0.50%
Market Cap	1.38B	Forward P/E	39.31	EPS next Y	0.76	Insider Trans	0.23%	Shs Float	44.90M	Perf Month	-5.30%
Enterprise Value	1.11B	PEG	-	EPS next Q	0.19	Inst Own	109.97%	Short Float	6.92%	Perf Quarter	-4.82%
Income	-111.59M	P/S	2.28	EPS this Y	22.63%	Inst Trans	-5.11%	Short Ratio	6.01	Perf Half Y	7.14%
Sales	604.93M	P/B	0.82	EPS next Y	51.94%	ROA	-1.47%	Short Interest	3.11M	Perf YTD	-39.94%
Book/sh	36.55	P/C	4.29	EPS next 5Y	32.05%	ROE	-1.74%	52W High	55.63 -46.02%	Perf Year	-25.61%
Cash/sh	7.01	P/FCF	30.14	EPS past 3/5Y	- -	ROIC	-6.46%	52W Low	23.91 25.60%	Perf 3Y	-47.08%
Dividend Est.	-	EV/EBITDA	26.33	Sales past 3/5Y	8.51% -3.41%	Gross Margin	43.11%	Volatility	3.33% 3.82%	Perf 5Y	-56.15%
Dividend TTM	-	EV/Sales	1.83	EPS Y/Y TTM	13.50%	Oper. Margin	-4.08%	ATR (14)	1.15	Perf 10Y	175.00%
Dividend Ex-Date	Dec 02, 2021	Quick Ratio	2.44	Sales Y/Y TTM	-8.15%	Profit Margin	-18.45%	RSI (14)	47.59	Recom	2.62
Dividend Gr. 3/5Y	- -	Current Ratio	2.76	EPS Q/Q	-828.00%	SMA20	-0.88%	Beta	1.29	Target Price	33.29
Payout	-	Debt/Eq	0.03	Sales Q/Q	-16.70%	SMA50	-1.82%	Rel Volume	0.41	Prev Close	30.03
Employees	3300	LT Debt/Eq	0.03	Earnings	Nov 21 BMO	SMA200	-6.40%	Avg Volume	516.91K	Price	30.03
IPO	Feb 02, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	39.40% -3.64%	Trades		Volume	128,712	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-30-25	Upgrade	Jefferies	Hold → Buy	$38
Aug-06-25	Upgrade	Raymond James	Mkt Perform → Outperform	$35
Jul-22-25	Resumed	Stephens	Equal-Weight	$35
Dec-18-24	Upgrade	Stephens	Equal-Weight → Overweight	$50 → $60
Apr-04-24	Initiated	Jefferies	Hold	$64
Feb-01-24	Reiterated	B. Riley Securities	Buy	$61 → $79
Jul-19-23	Initiated	Raymond James	Mkt Perform
May-10-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Feb-09-23	Downgrade	Stephens	Overweight → Equal-Weight	$65 → $60
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line	$60 → $62
Mar-31-22	Resumed	B. Riley Securities	Buy	$106
Mar-21-22	Initiated	Evercore ISI	Outperform	$100

Show Previous Ratings

Nov-19-25 10:01PM	Azenta (AZTA) Reports Q3: Everything You Need To Know Ahead Of Earnings (StockStory)
Nov-12-25 04:05PM	Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast (PR Newswire)
Nov-10-25 05:20PM	Outset Medical, Inc. (OM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-06-25 06:05PM	TruBridge (TBRG) Q3 Earnings and Revenues Surpass Estimates (Zacks)
Nov-05-25 07:05PM	Senseonics Holdings (SENS) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:05PM	Loading…
Nov-04-25 04:05PM	Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer (PR Newswire)
Oct-15-25 08:00AM	Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana (PR Newswire)
Sep-09-25 08:44AM	TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell? (Zacks)
Sep-02-25 08:04AM	Here's What Pressured Azenta (AZTA) in Q2 (Insider Monkey)
Aug-25-25 11:36PM	Spotting Winners: Azenta (NASDAQ:AZTA) And Drug Development Inputs & Services Stocks In Q2 (StockStory)
Aug-21-25 12:02AM	3 Reasons to Avoid AZTA and 1 Stock to Buy Instead (StockStory)
Aug-13-25 05:50PM	Azenta, LifeStance Health Group, BioMarin Pharmaceutical, AMN Healthcare Services, and ANI Pharmaceuticals Stocks Trade Up, What You Need To Know (StockStory) +9.83%
12:13AM	The Top 5 Analyst Questions From Azenta's Q2 Earnings Call (StockStory)
12:11AM	AZTA Q2 Deep Dive: Product Mix Shifts and Cost Controls Define Flat Quarter (StockStory)
Aug-07-25 03:36PM	Why Azenta (AZTA) Stock Is Up Today (StockStory)
02:50PM	Loading…
Aug-06-25 02:50PM	Azenta (AZTA) Stock Trades Up, Here Is Why (StockStory) +5.58%
Aug-05-25 12:40PM	Why Azenta (AZTA) Stock Is Trading Lower Today (StockStory) -17.00%
07:16AM	Azenta (NASDAQ:AZTA) Misses Q2 Sales Targets (StockStory)
06:30AM	Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance (PR Newswire)
Aug-03-25 11:10PM	Azenta (AZTA) Q2 Earnings Report Preview: What To Look For (StockStory)
Jul-31-25 04:05PM	Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology (PR Newswire)
08:30AM	Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care (PR Newswire)
Jul-30-25 04:05PM	Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
Jul-23-25 04:05PM	Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-25 02:06PM	Why Azenta (AZTA) Stock Is Up Today (StockStory) +5.11%
Jul-17-25 11:31PM	Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jul-16-25 11:33PM	Q1 Earnings Outperformers: Azenta (NASDAQ:AZTA) And The Rest Of The Drug Development Inputs & Services Stocks (StockStory)
Jun-02-25 12:02AM	3 Reasons to Sell AZTA and 1 Stock to Buy Instead (StockStory)
May-13-25 04:05PM	Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development (PR Newswire)
May-08-25 03:11AM	Azenta Inc (AZTA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Macroeconomic ... (GuruFocus.com) +9.70%
01:45PM	Loading…
May-07-25 01:45PM	Azenta targets 3%-5% organic growth and expands automation initiatives for FY2025 (Seeking Alpha)
01:44PM	Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript (Seeking Alpha)
09:35AM	Netflix Investors Unfazed by Tariffs With Growth Engine Humming (Bloomberg)
06:30AM	Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025 (PR Newswire)
Apr-29-25 09:01AM	2 Cash-Heavy Stocks Worth Your Attention and 1 to Approach with Caution (StockStory)
Apr-24-25 04:15PM	Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast (PR Newswire) +5.16%
Apr-17-25 09:31AM	Azenta: Life Science Business Failing To Come To Life (Seeking Alpha)
Mar-27-25 05:13AM	3 Reasons AZTA is Risky and 1 Stock to Buy Instead (StockStory)
Mar-24-25 04:05PM	Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report (PR Newswire)
Mar-10-25 05:05PM	Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum (PR Newswire) -6.62%
Feb-05-25 08:23AM	Azentas (NASDAQ:AZTA) Q4 Sales Top Estimates (StockStory)
07:00AM	Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 (PR Newswire)
Feb-04-25 03:59PM	Is Azenta (AZTA) the Mid-Cap Stock Insiders Are Buying Recently? (Insider Monkey)
Jan-30-25 04:05PM	Azenta Announces the Election of Dipal Doshi to its Board of Directors (PR Newswire)
Jan-27-25 04:05PM	Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Jan-23-25 04:05PM	UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence (PR Newswire)
Nov-29-24 01:00AM	Azenta, Inc. Navigates Global Data Protection Laws Amid Business Risks (TipRanks)
Nov-19-24 05:56PM	Flex Set to Join SandP MidCap 400; Azenta and Concentra Group Holdings to Join SandP SmallCap 600 (PR Newswire) +9.14%
05:56PM	Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600 (PR Newswire)
Nov-14-24 08:00AM	Azenta to Participate in Stephens Annual Investment Conference (PR Newswire)
Nov-13-24 02:17AM	Azenta Inc (AZTA) Q4 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic ... (GuruFocus.com)
Nov-12-24 04:05PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO (PR Newswire)
Nov-04-24 04:05PM	Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire) +8.93%
08:00AM	Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value (PR Newswire)
Oct-30-24 04:05PM	Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test (PR Newswire)
Sep-04-24 08:00AM	AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO (PR Newswire)
Aug-12-24 04:05PM	GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event (PR Newswire)
Aug-06-24 04:05PM	Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024 (PR Newswire) -8.93%
Aug-05-24 04:05PM	Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference (PR Newswire)
Jul-24-24 04:05PM	Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast (PR Newswire)
Jul-22-24 04:05PM	FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study (PR Newswire) +8.10%
Jun-04-24 04:05PM	Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research (PR Newswire)
May-23-24 04:05PM	Azenta to Participate in the Jefferies Global Healthcare Conference (PR Newswire)
May-14-24 06:34AM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Robotics Stocks (InvestorPlace)
May-13-24 04:46PM	Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK (PR Newswire)
May-10-24 01:07PM	Azenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges (GuruFocus.com)
May-09-24 12:53PM	Azenta, Inc. (NASDAQ:AZTA) Q2 2024 Earnings Call Transcript (Insider Monkey)
May-08-24 08:58PM	AZTA Stock Earnings: Azenta Beats EPS, Misses Revenue for Q2 2024 (InvestorPlace)
04:06PM	Azenta Announces CEO Succession Plan (PR Newswire)
04:05PM	Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024 (PR Newswire)
May-01-24 04:05PM	Azenta Announces Fiscal 2024 Second Quarter Earnings Conference Call and Webcast (PR Newswire)
Apr-25-24 11:28AM	11 Oversold MidCap Stocks To Buy Now (Insider Monkey)
Apr-01-24 04:15PM	Azenta Publishes its 2023 Environmental, Social, & Governance (ESG) Report (PR Newswire)
04:05PM	Azenta to Participate in the 23rd Annual Needham Virtual Healthcare Conference (PR Newswire)
Mar-12-24 08:00AM	Azenta to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum (PR Newswire)
Feb-08-24 10:53AM	Azenta, Inc. (NASDAQ:AZTA) Q1 2024 Earnings Call Transcript (Insider Monkey)
Feb-07-24 05:02PM	Azenta Inc (AZTA) Faces Revenue Decline and EPS Drop in Q1 Fiscal 2024 (GuruFocus.com)
04:05PM	Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023 (PR Newswire)
Feb-02-24 08:00AM	Azenta Launches the BioArc Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management (PR Newswire)
Jan-25-24 04:05PM	Azenta Announces Fiscal 2024 First Quarter Earnings Conference Call and Webcast (PR Newswire)
Jan-11-24 04:05PM	Azenta to Host Investor Day on March 14, 2024 (PR Newswire)
Jan-09-24 04:05PM	Azenta to Participate in the 26th Annual Needham Growth Conference (PR Newswire)
Jan-03-24 04:05PM	Azenta to Participate in the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Nov-21-23 04:05PM	Azenta to Participate in the 6th Annual Evercore ISI HealthCONx Conference (PR Newswire)
Nov-14-23 01:06PM	Azenta, Inc. (NASDAQ:AZTA) Q4 2023 Earnings Call Transcript (Insider Monkey) +13.89%
Nov-13-23 05:04PM	Azenta Inc (AZTA) Reports Revenue Growth in Q4 and FY 2023 Despite Earnings Pressure (GuruFocus.com)
04:07PM	Azenta Reports Fourth Quarter and Full Year Fiscal 2023 Results, Ended September 30, 2023 (PR Newswire)
04:06PM	Azenta Announces Actions to Support Ongoing Strategic and Governance Transformation (PR Newswire)
04:05PM	Azenta Announces Agreement Between B Medical and The Ministry of Public Health, Hygiene and Prevention of the Democratic Republic of the Congo for a Significant National Universal Health Project (PR Newswire)
Nov-10-23 04:05PM	Azenta to Participate in the Stephens Annual Investment Conference (PR Newswire)
Nov-08-23 04:05PM	Azenta Announces Fiscal 2023 Fourth Quarter and Full Year Earnings Conference Call and Webcast (PR Newswire)
Oct-19-23 04:05PM	Azenta to Host GENEWIZ Week November 6-10, 2023 (PR Newswire)
Sep-26-23 08:00AM	Azenta Announces CFO Transition (PR Newswire)
Sep-08-23 04:05PM	Azenta to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (PR Newswire)
Sep-07-23 04:05PM	Azenta to Participate in the Baird 2023 Global Healthcare Conference (PR Newswire)
Aug-10-23 08:00AM	Azenta to Participate in the UBS MedTech, Tools and Genomics Summit 2023 (PR Newswire)
Aug-09-23 04:05PM	Azenta to Participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1X1 Conference (PR Newswire) +20.33%
12:00PM	Azenta (NASDAQ:AZTA) lifts 4.0% this week, taking five-year gains to 70% (Simply Wall St.)
Aug-08-23 04:05PM	Azenta Reports Results of Third Quarter of Fiscal 2023, Ended June 30, 2023 (PR Newswire)
Aug-03-23 04:05PM	Azenta Announces Fiscal 2023 Third Quarter Earnings Conference Call and Webcast (PR Newswire)

Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. It operates through the Life Sciences Products and Life Sciences Services segments. The Life Sciences Products segment is involved in automated cold storage solutions for biological and chemical compound samples. The Life Sciences Services segment focuses on the solutions addressing the many needs of customers in the area of genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development markets. The company was founded in 1978 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Marotta John	President and CEO	Sep 10 '25	Sale	29.41	316	9,294	105,980	Sep 12 04:10 PM
Lin Lawrence Y.	EVP, CFO and Treasurer	Aug 11 '25	Buy	27.96	2,500	69,900	46,013	Aug 12 04:05 PM
Hughes Violetta	VP, Chief Accounting Officer	Feb 03 '25	Sale	52.97	317	16,791	9,603	Feb 04 04:10 PM
Zhou Ginger	SVP and General Manager, Genom	Jan 31 '25	Buy	45.88	417	19,132	27,916	Feb 04 04:10 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Black Swan Sale

50% Off Elite

AZTA

Azenta Inc

Upgrade your FINVIZ experience